NanoViricides
NNVC
#10572
Rank
โ‚น3.32 B
Marketcap
โ‚น130.09
Share price
2.62%
Change (1 day)
2.37%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น42.56. In 2025 the company made an earnings per share (EPS) of -โ‚น60.93 an increase over its 2024 EPS that were of -โ‚น67.70.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น39.14-35.77%
2025-โ‚น60.93-10%
2024-โ‚น67.70-5.41%
2023-โ‚น71.575.71%
2022-โ‚น67.70-13.58%
2021-โ‚น78.34-66.11%
2020-โ‚น231.161.7%
2019-โ‚น227.29-10.98%
2018-โ‚น255.34-22.35%
2017-โ‚น328.85-10.53%
2016-โ‚น367.54375%
2015-โ‚น77.38-85.19%
2014-โ‚น522.2942.11%
2013-โ‚น367.5426.67%
2012-โ‚น290.16-6.25%
2011-โ‚น309.5014.28%
2010-โ‚น270.82100%
2009-โ‚น135.41-0%
2008-โ‚น135.41-33.33%
2007-โ‚น203.11-0%
2006-โ‚น203.114445.07%
2005-โ‚น4.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น251.47 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น122.40-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น439.11-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น309.28-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น147.01 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น139.28 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA